MedPath

Image validation of laryngeal and hypopharyngeal cancer with histopathology for radiotherapy.

Completed
Conditions
larygeal cancer
larynx carcinoma
10027655
Registration Number
NL-OMON33702
Lead Sponsor
niversitair Medisch Centrum Utrecht
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
28
Inclusion Criteria

Patients of the above population scheduled for total laryngectomy.
Informed consent

Exclusion Criteria

Patients with indications for primary radiotherapy.
Patients with contraindications for surgery.
Patients who meet exclusion criteria for MRI at 1.5 T as defined in the protocols of the radiology department.
Patients with contraindication for CT contrast administration as defined in the protocols of the radiology department.
Patients with insulin dependent diabetes mellitus.
no informed consent.

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The accuracy of the different image modalities to measure the tumour volume and<br /><br>outline as determined by comparison with histopathology as reference standard. </p><br>
Secondary Outcome Measures
NameTimeMethod
<p>· assessment of microscopic invasion of the tumour in the surrounding tissue by<br /><br>histopathology.<br /><br><br /><br>· determination of the interobserver variation for tumour delineation using the<br /><br>different image modalities.<br /><br><br /><br>· feasibility of diffusion weighted imaging for laryngeal and hypopharyngeal<br /><br>cancer.<br /><br><br /><br>· development of a clinical imaging protocol for gross tumour volume (GTV) and<br /><br>clinical tumour volume (CTV) delineation.</p><br>
© Copyright 2025. All Rights Reserved by MedPath